Welcome to the

Washington State Medical Oncology Society (WSMOS)

WSMOS membership represents majority of the medical cancer specialists treating cancer patients in Washington. Our mission is to support medical oncology clinicians in delivering the highest quality, value, and equitable care to all cancer patients in WA state.

check our

WSMOS News

March 9, 2021

Modi tempora incidunt

Eius modi tempora incidunt ut labore et dolore magnam aliquam quaerat voluptatem. Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam, nisi ut […]
March 2, 2021

Doloremque laudantium

Eius modi tempora incidunt ut labore et dolore magnam aliquam quaerat voluptatem. Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam, nisi ut […]
check our

Corporate Member News

January 27, 2023

The National Comprehensive Cancer Network® (NCCN®) revised its guidelines

The National Comprehensive Cancer Network® (NCCN®) revised its guidelines—now Ribociclib (KISQALI®) is the only CDK4/6 inhibitor in combination with an AI designated as a Category 1 […]
October 1, 2021

G1 Therapeutics J-Code Announcement

G1 Therapeutics, Inc. secures permanent J Code for COSELA™ (trilaciclib). The code, J1448, is effective on October 1, 2021. Visit COSELA.com for more information.
check our

Corporate Member News

January 27, 2023

The National Comprehensive Cancer Network® (NCCN®) revised its guidelines

The National Comprehensive Cancer Network® (NCCN®) revised its guidelines—now Ribociclib (KISQALI®) is the only CDK4/6 inhibitor in combination with an AI designated as a Category 1 […]
October 1, 2021

G1 Therapeutics J-Code Announcement

G1 Therapeutics, Inc. secures permanent J Code for COSELA™ (trilaciclib). The code, J1448, is effective on October 1, 2021. Visit COSELA.com for more information.